Not Tagged
eqrx
['lung', 'sclc', 'nsclc', 'eqrx']
see new data at asco 2022 on our investigational egfr inhibitor in treating patients with advanced egfr-mutated non-small cell lung cancer (nsclc) who have central nervous system (cns) metastases (abstract #:9096).
EQRx is a new type of pharmaceutical company committed to developing & delivering innovative medicines to patients at RADICALLY lower prices. #RemakingMedicine